Recall

Could cause harm

Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile,…

Lack of Assurance of Sterility

Official FDA data record

What to do

Does your product match this recall?

Scan your barcode or label to compare your product with this notice. We’ll help you check the lot or date code when needed.

Scan Barcode

No account or app download needed. A barcode may need a lot code to confirm a match.

  1. 1Compare the product, size and lot or date code with this notice.
  2. 2If your product matches, stop using it and follow the official recall instructions.
  3. 3Read the official notice for return, refund or disposal instructions.

What the notice says

Lack of Assurance of Sterility. This could cause temporary or reversible health problems.

Recall details

Firm
SCOPE HEALTH
Status
Ongoing
Reported
May 6, 2026
Started
Apr 20, 2026
Where sold
Nationwide within the United States
Notice number
D-0499-2026

Lots, UPC, dates

Lot#: 8T98, 9T31, 9T32, Exp. Date: 30/04/26; 2V13, 2V14, 2V15, Exp. Date 30/06/26; 3V35, Exp. Date 31/08/26;3V36, 3V37, Exp. Date 30/09/26; 5V45, 5V46, 9V12, Exp. Date 31/03/27; 1X57, 1X70, 1X84, Exp. Date 31/05/27.

Agency wording

Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.

Source: FDA OTC report. This is not medical advice. Compare your package codes before you act.